Unlock stock picks and a broker-level newsfeed that powers Wall Street.

LSE - Delayed Quote USD

Enovis Corporation (0I1B.L)

34.10
+2.26
+(7.09%)
At close: April 30 at 5:40:02 PM GMT+1
Loading Chart for 0I1B.L
  • Previous Close 31.84
  • Open 34.05
  • Bid --
  • Ask --
  • Day's Range 34.05 - 34.10
  • 52 Week Range 34.05 - 65.36
  • Volume 427
  • Avg. Volume 26
  • Market Cap (intraday) --
  • Beta (5Y Monthly) 1.97
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date May 8, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments. The company's Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. Its Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. It distributes its products through independent distributors and directly under the ESAB and DJO brands. The company was formerly known as Colfax Corporation. Enovis Corporation was founded in 1995 and is headquartered in Wilmington, Delaware.

www.enovis.com

7,367

Full Time Employees

December 31

Fiscal Year Ends

--

Sector

--

Industry

Recent News: 0I1B.L

View More

Performance Overview: 0I1B.L

Trailing total returns as of 5/2/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .

YTD Return

0I1B.L
0.00%
MSCI WORLD (^990100-USD-STRD)
1.15%

1-Year Return

0I1B.L
0.00%
MSCI WORLD (^990100-USD-STRD)
10.34%

3-Year Return

0I1B.L
38.75%
MSCI WORLD (^990100-USD-STRD)
31.08%

5-Year Return

0I1B.L
38.75%
MSCI WORLD (^990100-USD-STRD)
82.83%

Compare To: 0I1B.L

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 0I1B.L

View More

Valuation Measures

Annual
As of
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -39.17%

  • Return on Assets (ttm)

    0.73%

  • Return on Equity (ttm)

    -27.65%

  • Revenue (ttm)

    2.11B

  • Net Income Avi to Common (ttm)

    -828.09M

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    48.17M

  • Total Debt/Equity (mrq)

    54.76%

  • Levered Free Cash Flow (ttm)

    11.92M

Research Analysis: 0I1B.L

View More

Company Insights: 0I1B.L

Research Reports: 0I1B.L

View More

People Also Watch